Literature DB >> 16754968

An improved resolution structure of the human beta common receptor involved in IL-3, IL-5 and GM-CSF signalling which gives better definition of the high-affinity binding epitope.

P D Carr1, F Conlan, S Ford, D L Ollis, I G Young.   

Abstract

X-ray diffraction has been used to produce and refine a model of the extracellular domains of the beta common cytokine receptor. A minor improvement in resolution has resulted in improved electron-density maps, which have given a clearer indication of the position and stabilization of the key residues Tyr15, Phe79, Tyr347, His349, Ile350 and Tyr403 in the elbow region between domain 1 and domain 4 of the dimer-related molecule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16754968      PMCID: PMC2243076          DOI: 10.1107/S1744309106016812

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  20 in total

1.  Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration.

Authors:  P D Carr; S E Gustin; A P Church; J M Murphy; S C Ford; D A Mann; D M Woltring; I Walker; D L Ollis; I G Young
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

2.  SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model.

Authors:  A A Vaguine; J Richelle; S J Wodak
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-01-01

3.  Expression, crystallization and derivatization of the complete extracellular domain of the beta(c) subunit of the human IL-5, IL-3 and GM-CSF receptors.

Authors:  S E Gustin; A P Church; S C Ford; D A Mann; P D Carr; D L Ollis; I G Young
Journal:  Eur J Biochem       Date:  2001-05

4.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

5.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

Authors:  M D Winn; M N Isupov; G N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-01

6.  Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.

Authors:  A W Mould; K I Matthaei; I G Young; P S Foster
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  Structure of the activation domain of the GM-CSF/IL-3/IL-5 receptor common beta-chain bound to an antagonist.

Authors:  J Rossjohn; W J McKinstry; J M Woodcock; B J McClure; T R Hercus; M W Parker; A F Lopez; C J Bagley
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

8.  Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains.

Authors:  James M Murphy; Sally C Ford; Jane E Olsen; Sonja E Gustin; Peter D Jeffrey; David L Ollis; Ian G Young
Journal:  J Biol Chem       Date:  2004-04-01       Impact factor: 5.157

9.  Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

Authors:  J L McQualter; R Darwiche; C Ewing; M Onuki; T W Kay; J A Hamilton; H H Reid; C C Bernard
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

10.  Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.

Authors:  A D Cook; E L Braine; I K Campbell; M J Rich; J A Hamilton
Journal:  Arthritis Res       Date:  2001-06-11
View more
  8 in total

Review 1.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 2.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 3.  The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.

Authors:  Timothy R Hercus; Daniel Thomas; Mark A Guthridge; Paul G Ekert; Jack King-Scott; Michael W Parker; Angel F Lopez
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

4.  Computational design and experimental characterization of a novel β-common receptor inhibitory peptide.

Authors:  Cody R Kilar; Sivakumar Sekharan; Larysa Sautina; YanPeng Diao; Shahar Keinan; Yong Shen; Jorg Bungert; Rajesh Mohandas; Mark S Segal
Journal:  Peptides       Date:  2018-04-07       Impact factor: 3.750

5.  Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging.

Authors:  Meirav Zaks-Zilberman; Adrian E Harrington; Tetsuya Ishino; Irwin M Chaiken
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

6.  The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities.

Authors:  Urmi Dhagat; Timothy R Hercus; Sophie E Broughton; Tracy L Nero; Karen S Cheung Tung Shing; Emma F Barry; Christy A Thomson; Steve Bryson; Emil F Pai; Barbara J McClure; John W Schrader; Angel F Lopez; Michael W Parker
Journal:  MAbs       Date:  2018-09-12       Impact factor: 5.857

7.  EPO does not promote interaction between the erythropoietin and beta-common receptors.

Authors:  Karen S Cheung Tung Shing; Sophie E Broughton; Tracy L Nero; Kevin Gillinder; Melissa D Ilsley; Hayley Ramshaw; Angel F Lopez; Michael D W Griffin; Michael W Parker; Andrew C Perkins; Urmi Dhagat
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

8.  CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.

Authors:  Con Panousis; Urmi Dhagat; Kirsten M Edwards; Veronika Rayzman; Matthew P Hardy; Hal Braley; Gail M Gauvreau; Timothy R Hercus; Steven Smith; Roma Sehmi; Laura McMillan; Mara Dottore; Barbara J McClure; Louis J Fabri; Gino Vairo; Angel F Lopez; Michael W Parker; Andrew D Nash; Nicholas J Wilson; Michael J Wilson; Catherine M Owczarek
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.